Fig. 2
From: GNG2 inhibits brain metastases from colorectal cancer via PI3K/AKT/mTOR signaling pathway
The clinical characteristics of CRC patients. (A) Heat map of 88 CRC patients with clinical characteristics. (B, C) Patients with varying GNG2 expression levels displayed differences in their overall survival (OS).
